SMYD2A anticorps (Middle Region)
-
- Antigène Voir toutes SMYD2A Anticorps
- SMYD2A (SET and MYND Domain Containing 2a (SMYD2A))
-
Épitope
- Middle Region
-
Reactivité
- Humain, Souris, Rat, Boeuf (Vache), Chien, Cheval, Lapin, Cobaye, Porc, Poisson zèbre (Danio rerio)
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp SMYD2A est non-conjugé
-
Application
- Western Blotting (WB), Chromatin Immunoprecipitation (ChIP)
- Séquence
- SMWLKLGRLY MGLEHKAAGE KALKKAIAIM EVAHGKDHPY ISEIKQEIES
- Homologie
- Cow: 100%, Dog: 100%, Guinea Pig: 93%, Horse: 100%, Human: 100%, Mouse: 100%, Pig: 100%, Rabbit: 100%, Rat: 100%, Zebrafish: 86%
- Attributs du produit
- This is a rabbit polyclonal antibody against SMYD2. It was validated on Western Blot using a cell lysate as a positive control.
- Purification
- Affinity Purified
- Immunogène
- The immunogen is a synthetic peptide directed towards the middle region of human SMYD2
- Top Product
- Discover our top product SMYD2A Anticorps primaire
-
-
- Indications d'application
- Optimal working dilutions should be determined experimentally by the investigator.
- Commentaires
-
Antigen size: 433 AA
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
Primary central nervous system lymphoma in Japan: changes in clinical features, treatment, and prognosis during 1985-2004." dans: Neuro-oncology, Vol. 10, Issue 4, pp. 560-8, (2008) (PubMed).
: "
-
Primary central nervous system lymphoma in Japan: changes in clinical features, treatment, and prognosis during 1985-2004." dans: Neuro-oncology, Vol. 10, Issue 4, pp. 560-8, (2008) (PubMed).
-
- Antigène
- SMYD2A (SET and MYND Domain Containing 2a (SMYD2A))
- Autre désignation
- SMYD2 (SMYD2A Produits)
- Synonymes
- anticorps HSKM-B, anticorps KMT3C, anticorps ZMYND14, anticorps 1110020E07Rik, anticorps 4930402C15, anticorps Zmynd14, anticorps smyd2-a, anticorps im:7146196, anticorps smyd2, anticorps wu:fc02f02, anticorps zgc:110553, anticorps si:dkey-121j17.3, anticorps zgc:136609, anticorps SET and MYND domain containing 2, anticorps SET and MYND domain containing 2 S homeolog, anticorps SET and MYND domain containing 2a, anticorps SET and MYND domain containing 2b, anticorps SMYD2, anticorps Smyd2, anticorps smyd2.S, anticorps smyd2a, anticorps smyd2b
- Sujet
-
The specific function of this protein remains unknown.SET domain-containing proteins, such as SMYD2, catalyze lysine methylation (Brown et al., 2006 [PubMed 16805913]).[supplied by OMIM].
Alias Symbols: HSKM-B, KMT3C, MGC119305, ZMYND14
Protein Interaction Partner: UBC, HIST2H3C, HSP90AA1, RB1, EPB41L3, TP53, CLASP2, AKAP11, CDC37, IGF2BP1, AXIN1, GSK3B,
Protein Size: 433 - Poids moléculaire
- 50 kDa
- ID gène
- 56950
- NCBI Accession
- NM_020197, NP_064582
- UniProt
- Q9NRG4
-